Prescription drug · ANDA
Amphotericin B NDC 23155-594
Amphotericin b 50 mg/1 · Injectable, Liposomal · Intravenous · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 23155-594-31 | 23155059431 | 1 VIAL, SINGLE-DOSE in 1 CARTON (23155-594-31) / 1 INJECTABLE, LIPOSOMAL in 1 VIAL, SINGLE-DOSEMarketed from Jun 20, 2025 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Amphotericin B
- Generic name (nonproprietary)
- amphotericin b
- Active ingredients
- Amphotericin b — 50 mg/1
- Dosage form
- Injectable, Liposomal
- Route
- Intravenous
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 215354
- Marketing start
- Listing expires
- Other FDA classes
- Polyenes (Chemical structure)
- Identifiers
- Product ID 23155-594_9de2927d-27ac-4890-ad71-a737dd4d3881SPL ID 9de2927d-27ac-4890-ad71-a737dd4d3881SPL set ID 2b2f3ff5-9d62-4ad2-8eac-1181e5911513RxCUI 967385UNII 7XU7A7DROEUPC 0323155594317
- Pharmacologic class
- Lipid-based Polyene Antifungal; Polyene Antifungal
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N423155059431followed by a unit qualifier and the quantityPackage 23155-0594-31. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Amphotericin B liposome for injection is indicated for the following: Empirical therapy for presumed fungal infection in febrile, neutropenic patients. Treatment of Cryptococcal Meningitis in HIV-infected patients (see DESCRIPTION OF CLINICAL STUDIES ). Treatment of patients with Aspergillus species, Candida species and/or Cryptococcus species infections (see above for the treatment of Cryptococcal Meningitis) refractory to amphotericin B deoxycholate, or in patients where renal impairment or unacceptable toxicity precludes the use of amphotericin B deoxycholate. Treatment of visceral leishmaniasis. In immunocompromised patients with visceral leishmaniasis treated with …
Excerpt only. Read the full label for complete information.